We are live on ! Find out more
OGC

Oak Grove Capital Portfolio holdings

AUM $1.18B
1-Year Est. Return 84.79%
This Fund
S&P 500
This Quarter Est. Return
+5.97%
1 Year Est. Return
+84.79%
3 Year Est. Return
+236.05%
5 Year Est. Return
+282.98%
10 Year Est. Return
AUM
$187M
AUM Growth
+$28.2M
Cap. Flow
+$22.9M
Cap. Flow %
12.28%
Top 10 Hldgs %
55.4%
Holding
77
New
13
Increased
22
Reduced
25
Closed
10

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$5.08M
2
AMZN icon
Amazon
AMZN
+$2.7M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$2.54M
4
JPM icon
JPMorgan Chase
JPM
+$1.93M
5
DD icon
DuPont de Nemours
DD
+$1.37M

Sector Composition

Rank Sector Weight
1 Technology 42.42%
2 Communication Services 15.03%
3 Consumer Discretionary 9.48%
4 Financials 6.02%
5 Industrials 4.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
51
Merck
MRK
$322B
$487K 0.26%
6,088
-209
-3% -$16K
GD icon
52
General Dynamics
GD
$103B
$482K 0.26%
2,650
-2,145
-45% -$369K
JPM icon
53
JPMorgan Chase
JPM
$916B
$466K 0.25%
4,166
-17,534
-81% -$1.93M
WMT icon
54
Walmart Inc
WMT
$909B
$447K 0.24%
+12,150
New +$419K
LBTYK icon
55
Liberty Global Class C
LBTYK
$3.5B
$440K 0.24%
16,600
-3,000
-15% -$77.1K
IEMG icon
56
iShares Core MSCI Emerging Markets ETF
IEMG
$144B
$435K 0.23%
8,450
V icon
57
Visa
V
$677B
$431K 0.23%
+2,485
New +$407K
IYH icon
58
iShares US Healthcare ETF
IYH
$3.44B
$400K 0.21%
10,250
OGE icon
59
OGE Energy
OGE
$9.87B
$305K 0.16%
7,160
ATVI
60
DELISTED
Activision Blizzard
ATVI
$291K 0.16%
6,171
-25,700
-81% -$1.18M
CCI icon
61
Crown Castle
CCI
$34.6B
$251K 0.13%
+1,923
New +$247K
IBB icon
62
iShares Biotechnology ETF
IBB
$9.45B
$251K 0.13%
2,300
-100
-4% -$10.6K
IDXX icon
63
Idexx Laboratories
IDXX
$44.9B
$245K 0.13%
+890
New +$219K
LILAK icon
64
Liberty Latin America Class C
LILAK
$1.69B
$232K 0.12%
15,739
IGV icon
65
iShares Expanded Tech-Software Sector ETF
IGV
$12.4B
$206K 0.11%
+4,705
New +$202K
AAPL icon
66
PUT
Apple
AAPL
$4.97T
$17K 0.01%
+40,000
New +$1.95M
AVGO icon
67
PUT
Broadcom
AVGO
$1.76T
$7K ﹤0.01%
+4,000
New +$117K
AMAT icon
68
Applied Materials
AMAT
$347B
-12,000
Closed -$476K
C icon
69
Citigroup
C
$213B
-4,050
Closed -$252K
EMGF icon
70
iShares Emerging Markets Equity Factor ETF
EMGF
$1.74B
-15,050
Closed -$643K
EPD icon
71
Enterprise Products Partners
EPD
$83.7B
-23,750
Closed -$691K
JNJ icon
72
Johnson & Johnson
JNJ
$640B
-3,550
Closed -$496K
LRCX icon
73
PUT
Lam Research
LRCX
$316B
-200,000
Closed -$15K
NVDA icon
74
PUT
NVIDIA
NVDA
$4.6T
-400,000
Closed -$12K
TAK icon
75
Takeda Pharmaceutical
TAK
$56.7B
-53,946
Closed -$1.1M

Similar funds

Oak Grove Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Oak Grove Capital held 77 positions worth $187M, up 18% from $159M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Oak Grove Capital deployed $22.9M of net new capital in Q2 2019, opening 13 new positions and adding to 22 existing holdings. Its largest new stake was Broadcom: 401,330 shares worth $11.6M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 37% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Alibaba, an estimated $5.08M trimmed.

  • Oak Grove Capital's largest Q2 2019 buy was Broadcom: 401,330 shares worth $11.6M.
  • Oak Grove Capital added most to Gilead Sciences in Q2 2019, an estimated $3.47M increase.
  • Oak Grove Capital's biggest Q2 2019 reduction was Alibaba, cutting an estimated $5.08M.
  • Oak Grove Capital fully exited Takeda Pharmaceutical in Q2 2019, selling an estimated $1.1M.
  • Oak Grove Capital's ten largest holdings make up 55% of its $187M portfolio in Q2 2019.
  • Oak Grove Capital opened 13 new positions and closed 10 in Q2 2019.
  • Oak Grove Capital's portfolio value rose 18% quarter-over-quarter to $187M.

Based on Oak Grove Capital's 13F filing for Q2 2019, filed 9 Aug 2019.